Claire Mazumdar is the founder of Bicara Therapeutics. Bicara Therapeutics has raised $165M in total funding. Latest round: Series C. Backed by Eight Roads.
Claire Mazumdar is the founding CEO of Bicara Therapeutics. Previously, she led business development and corporate strategy at Rheos Medicines and was a Senior Associate at Third Rock Ventures, focusing on company formation and supporting business development for TRV portfolio companies. She holds a Bachelor of Science in Biological Engineering from MIT, an MBA from Stanford Graduate School of Business, and a PhD in Cancer Biology from Stanford School of Medicine. Her research in tumor immunology and cancer epigenetics has been published in Nature, Cell Stem Cell, and Cancer Cell.
Full founder directory · Investor directory · Company funding database · Fundraising library